BACKGROUND: Use of tobacco products, excessive alcohol consumption, and high-risk sexual behaviors increase the risk of developing head and neck cancer and impacts treatment effectiveness after diagnosis. This study examined smoking and engagement in other modifiable behavioral risk factors and human papillomavirus (HPV) status in patients with head and neck cancer in order to facilitate identification and foster development of targeted interventions in high-risk patients. METHODS: Participants were 102 patients with head and neck cancer at a large urban cancer center who completed a self-report background and health questionnaire and provided a saliva sample for determination of the long-acting nicotine metabolite cotinine. RESULTS: Compared with former and never-smokers, current smokers were less educated, less likely to be married or living with a partner, and consumed more alcohol. Cotinine analysis indicated that 4 of 16 (25%) patients who denied past-month cigarette use misrepresented their true smoking status. Of patients with oropharyngeal cancer, 74% were confirmed as HPV-positive, and compared with HPV-negative patients, they were younger, more likely to be married/partnered and of Caucasian race, and reported more past vaginal and oral sexual partners. Only one-third of HPV-positive patients were aware of their HPV disease status. CONCLUSIONS: Cigarette smoking is associated with engagement in other modifiable risk factors in patients with head and neck cancer. Self-report measures of smoking may not accurately depict true smoking status. HPV-positive cancer patients were more likely to endorse a history of multiple sexual partners. Regular screening and targeted interventions for these distinct risk factors are warranted.
BACKGROUND: Use of tobacco products, excessive alcohol consumption, and high-risk sexual behaviors increase the risk of developing head and neck cancer and impacts treatment effectiveness after diagnosis. This study examined smoking and engagement in other modifiable behavioral risk factors and human papillomavirus (HPV) status in patients with head and neck cancer in order to facilitate identification and foster development of targeted interventions in high-risk patients. METHODS:Participants were 102 patients with head and neck cancer at a large urban cancer center who completed a self-report background and health questionnaire and provided a saliva sample for determination of the long-acting nicotine metabolite cotinine. RESULTS: Compared with former and never-smokers, current smokers were less educated, less likely to be married or living with a partner, and consumed more alcohol. Cotinine analysis indicated that 4 of 16 (25%) patients who denied past-month cigarette use misrepresented their true smoking status. Of patients with oropharyngeal cancer, 74% were confirmed as HPV-positive, and compared with HPV-negative patients, they were younger, more likely to be married/partnered and of Caucasian race, and reported more past vaginal and oral sexual partners. Only one-third of HPV-positive patients were aware of their HPV disease status. CONCLUSIONS: Cigarette smoking is associated with engagement in other modifiable risk factors in patients with head and neck cancer. Self-report measures of smoking may not accurately depict true smoking status. HPV-positive cancerpatients were more likely to endorse a history of multiple sexual partners. Regular screening and targeted interventions for these distinct risk factors are warranted.
Authors: W J Blot; J K McLaughlin; D M Winn; D F Austin; R S Greenberg; S Preston-Martin; L Bernstein; J B Schoenberg; A Stemhagen; J F Fraumeni Journal: Cancer Res Date: 1988-06-01 Impact factor: 12.701
Authors: Marcela Fu; Esteve Fernández; José A Pascual; Jose M Martínez-Sánchez; Antoni Agudo; Albert Moncada; Manel Nebot; Josep M Borràs Journal: Prev Med Date: 2010-12-14 Impact factor: 4.018
Authors: Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek Journal: Cancer Causes Control Date: 2010-04-17 Impact factor: 2.506
Authors: Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison Journal: Oral Oncol Date: 2012-07-28 Impact factor: 5.337
Authors: Andrea E Potash; Lucy Hynds Karnell; Alan J Christensen; Mark W Vander Weg; Gerry F Funk Journal: Head Neck Date: 2010-07 Impact factor: 3.147
Authors: Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver Journal: Laryngoscope Date: 2016-07-09 Impact factor: 3.325
Authors: C P Vlooswijk; P H E van Rooij; J C Kruize; H A Schuring; A Al-Mamgani; N M de Roos Journal: Eur J Clin Nutr Date: 2015-07-22 Impact factor: 4.016
Authors: Prokopios P Argyris; Zachary Slama; Chris Malz; Ioannis G Koutlas; Betty Pakzad; Ketan Patel; Deepak Kademani; Ali Khammanivong; Mark C Herzberg Journal: Oral Oncol Date: 2019-06-04 Impact factor: 5.337
Authors: Katherine R Sterba; Kathryn E Weaver; Anthony J Alberg; Mitchell L Worley; Janet A Tooze; Jeanne L Hatcher; Matthew J Carpenter; Terry A Day; Christopher A Sullivan; Graham W Warren Journal: Otolaryngol Head Neck Surg Date: 2015-07-20 Impact factor: 3.497
Authors: E Lukesova; J Boucek; E Rotnaglova; M Salakova; E Koslabova; M Grega; T Eckschlager; B Rihova; B Prochazka; J Klozar; R Tachezy Journal: Biomed Res Int Date: 2014-04-23 Impact factor: 3.411
Authors: Nam P Nguyen; Ly M Nguyen; Sroka Thomas; Bevan Hong-Ly; Alexander Chi; Paul Vos; Ulf Karlsson; Vincent Vinh-Hung Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889
Authors: Kristen McCarter; Úrsula Martínez; Ben Britton; Amanda Baker; Billie Bonevski; Gregory Carter; Alison Beck; Chris Wratten; Ashleigh Guillaumier; Sean A Halpin; Luke Wolfenden Journal: BMJ Open Date: 2016-09-20 Impact factor: 2.692